The weekly litigation news digest is live. Subscribe now

IP Verse

Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiv

Patent No. EP2322930 (titled "Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiv") was filed by Becton Dickinson Infusion Therapy Systems on Oct 10, 2006. The application was issued on Jul 14, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BECKMAN COULTERApr 13, 2022BOULT WADE TENNANT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2322930

BECTON DICKINSON INFUSION THERAPY SYSTEMS
Application Number
EP10016074A
Filing Date
Oct 10, 2006
Status
Granted And Under Opposition
Jun 11, 2021
Publication Date
Jul 14, 2021
External Links
Slate, EP2322930B1, Google Patents